Journal: Antimicrobial Agents and Chemotherapy

Article Title: Comparing the Clinical Utility of Rapid Diagnostics for Treatment of Bloodstream Infections Using Desirability of Outcome Ranking Approach for the Management of Antibiotic Therapy (DOOR-MAT)

doi: 10.1128/AAC.00441-21

Figure Lengend Snippet: Clinical isolates by final susceptibility phenotype profile among Gram-negative and Gram-positive organisms by treatment based on results of ePlex BCID panels versus Verigene BC. Comparison of theoretical antibiotic management decisions based on GenMark ePlex BCID RUO or Vergine BC results by final organism susceptibility profile. NA, no routine susceptibility testing (e.g., coagulase-negative Staphylococcus ) or uncommon profile (e.g., Stenotrophomonas maltophilia ).

Article Snippet: The GenMark Dx ePlex blood culture identification (BCID) (research use only) Gram-positive (BCID-GP) and Gram-negative (BCID-GN) panels were used for retained blood samples that were frozen at −80°C.

Techniques: Comparison

Journal: Antimicrobial Agents and Chemotherapy

Article Title: Comparing the Clinical Utility of Rapid Diagnostics for Treatment of Bloodstream Infections Using Desirability of Outcome Ranking Approach for the Management of Antibiotic Therapy (DOOR-MAT)

doi: 10.1128/AAC.00441-21

Figure Lengend Snippet: Comparison of RDT platforms

Article Snippet: The GenMark Dx ePlex blood culture identification (BCID) (research use only) Gram-positive (BCID-GP) and Gram-negative (BCID-GN) panels were used for retained blood samples that were frozen at −80°C.

Techniques: Comparison, Bacteria

Journal: JAC-Antimicrobial Resistance

Article Title: Molecular diagnostics for genotypic detection of antibiotic resistance: current landscape and future directions

doi: 10.1093/jacamr/dlad018

Figure Lengend Snippet: FDA-cleared tests for detection of microorganisms and antibiotic resistance genes or mutations

Article Snippet: Bacillus cereus group , Bacillus subtilis group, Corynebacterium species, C. acnes , Enterococcus species, E. faecalis , E. faecium , Lactobacillus species, Listeria species, L. monocytogenes , Micrococcus species, Staphylococcus species, S. aureus , S. epidermidis , S. lugdunensis , Streptococcus species, S. agalactiae , S. anginosus group, S. pneumoniae , S. pyogenes , ePlex BCID-GP (GenMark Diagnostics) , mecA , mecC , vanA , vanB , 2018 .

Techniques: Bla VIM Assay, Bacteria, Virus, Luminex, Transmission Electron Microscopy, Mutagenesis

Journal: Missouri Medicine

Article Title: Updates on Rapid Diagnostic Tests in Infectious Diseases

doi:

Figure Lengend Snippet: Turnaround time and pathogen targets of FDA-cleared multiplex blood culture identification panels

Article Snippet: There are currently four FDA-cleared molecular multiplex assays for blood culture pathogen identification: FilmArray BCID panel (bioMérieux, Marcy l’Etoile, France), Verigene Gram Positive Blood Culture ID assay (BCID-GP) and Gram Negative Blood Culture ID assay (BCID-GN) (Luminex Molecular Diagnostics, Toronto, Canada), Accelerate PhenoTest BC kit (Accelerate Diagnostics, Tucson, AZ), and ePlex Blood Culture Identification Gram-Positive Panel (BCID-GP) and Gram-Negative Panel (BCID-GN) (GenMark Diagnostics, Carlsbad, CA).

Techniques: Multiplex Assay, Bla VIM Assay